Difference between revisions of "Leadership"
Jump to navigation
Jump to search
[unchecked revision] | [unchecked revision] |
Line 3: | Line 3: | ||
[[File:Jennelle Hodge photo cropped.jpg|center|thumb|Jennelle C. Hodge, PhD, FACMG, Associate Professor, Department of Medical and Molecular Genetics, Indiana University; '''Editor-in-Chief CCGA''']] | [[File:Jennelle Hodge photo cropped.jpg|center|thumb|Jennelle C. Hodge, PhD, FACMG, Associate Professor, Department of Medical and Molecular Genetics, Indiana University; '''Editor-in-Chief CCGA''']] | ||
− | [[File:Fabiola-Quintero Riviera-orig 2019.jpg|center|thumb|Fabiola-Quintero-Rivera, MD, Professor, | + | [[File:Fabiola-Quintero Riviera-orig 2019.jpg|center|thumb|Fabiola-Quintero-Rivera, MD, Professor, Departments of Pathology and Laboratory Medicine and Pediatrics, University of California Irvine; '''Associate Editor CCGA [MDS/MPN Section]''']] |
[[File:Yassmine Akkari.png|center|thumb|Yassmine Akkari, PhD, FACMG, Scientific Director of Cytogenetics and Molecular Pathology, Manager of Genetics Laboratories Operations, Legacy Health; '''Associate Editor CCGA [ALL Section]''']] | [[File:Yassmine Akkari.png|center|thumb|Yassmine Akkari, PhD, FACMG, Scientific Director of Cytogenetics and Molecular Pathology, Manager of Genetics Laboratories Operations, Legacy Health; '''Associate Editor CCGA [ALL Section]''']] |
Revision as of 15:19, 2 August 2021
Meet your editors! We welcome questions and your participation in the CCGA.

Greg Corboy, PhD, Pathology Queensland (Queensland, Australia) School of Clinical Sciences, Monash University (Melbourne, Australia), Department of Clinical Pathology, The University of Melbourne (Melbourne, Australia); Co-Associate Editor CCGA [Mature B-Cell Neoplasms Section], Associate Editor CCGA [Hodgkin Lymphomas/Lymphoproliferative Disorders/Other Rare Entities Section]